We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Dottikon ES Holding AG (DESN) CHF0.01

Sell:213.00 CHF Buy:226.00 CHF Change: 2.00 CHF (0.92%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:213.00 CHF
Buy:226.00 CHF
Change: 2.00 CHF (0.92%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:213.00 CHF
Buy:226.00 CHF
Change: 2.00 CHF (0.92%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.

Contact details

Address:
5605
PO. Box
DOTTIKON
5605
Switzerland
Telephone:
+41 (56) 6168201
Website:
https://dottikon.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DESN
ISIN:
CH0582581713
Market cap:
3.06 billion CHF
Shares in issue:
13.77 million
Sector:
Pharmaceuticals
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Markus Blocher
    Executive Chairman of the Board, Chief Executive Officer, Managing Director
  • Marlene Born
    Chief Financial Officer
  • Karin Krause
    Head of Human Resources
  • Urs Braendli
    Head of Processes and Technologies
  • Robert Dahinden
    Head of Production
  • Stephan Kirschbaum
    Head of Business Development
  • Thomas Rosatzin
    Head of Purchasing
  • Rolf Schaller
    Head of Quality Management

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.